Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00102245Terminated

Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes

Showing all 1 trials

Research Network

Active Sponsors

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top Investigators

Related Conditions

  • Hemoglobinopathies1
  • Hemolysis1
  • Iron Deficiency And Overload1

Activity Timeline